psa screening

prostate-specific antigen

urological association education

active surveillance

Journal of the National Comprehensive Cancer Network

Peter H. Carroll, MD, MPH, and James L. Mohler, MD, updated attendees on what is new in the 2018 NCCN Guidelines for Prostate Cancer Early Detection and for Prostate Cancer, respectively. Their presentations touched on new screening recommendations, shared decision-making, risk stratification, the role of genomic and molecular testing, active surveillance, and newer systemic treatments.

NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection